44,821 Dead 4,351,483 Injured Following COVID-19 Vaccines in European Database of Adverse Reactions
by Brian Shilhavy
Editor, Health Impact News
The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 44,821 fatalities, and 4,351,483 injuries following injections of five experimental COVID-19 shots:
- COVID-19 MRNA VACCINE MODERNA (CX-024414)
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
- COVID-19 VACCINE JANSSEN (AD26.COV2.S)
- COVID-19 VACCINE NOVAVAX (NVX-COV2373)
From the total of injuries recorded, almost half of them (1,972,105) are serious injuries.
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”
Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*
Here is the summary data through May 21, 2022.
Total reactions for the mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 21,070 deaths and 2,207,919 injuries to 21/05/2022
- 67,512 Blood and lymphatic system disorders incl. 303 deaths
- 78,229 Cardiac disorders incl. 3,061 deaths
- 694 Congenital, familial and genetic disorders incl. 63 deaths
- 29,164 Ear and labyrinth disorders incl. 16 deaths
- 2,801 Endocrine disorders incl. 10 deaths
- 32,801 Eye disorders incl. 54 deaths
- 161,894 Gastrointestinal disorders incl. 837 deaths
- 550,894 General disorders and administration site conditions incl. 5,821 deaths
- 2,542 Hepatobiliary disorders incl. 121 deaths
- 24,583 Immune system disorders incl. 134 deaths
- 123,754 Infections and infestations incl. 2,182 deaths
- 41,268 Injury, poisoning and procedural complications incl. 441 deaths
- 53,565 Investigations incl. 582 deaths
- 14,151 Metabolism and nutrition disorders incl. 368 deaths
- 253,409 Musculoskeletal and connective tissue disorders incl. 287 deaths
- 2,466 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 241 deaths
- 348,167 Nervous system disorders incl. 2,266 deaths
- 3,188 Pregnancy, puerperium and perinatal conditions incl. 85 deaths
- 301 Product issues incl. 4 deaths
- 39,004 Psychiatric disorders incl. 242 deaths
- 8,112 Renal and urinary disorders incl. 312 deaths
- 95,775 Reproductive system and breast disorders incl. 8 deaths
- 92,246 Respiratory, thoracic and mediastinal disorders incl. 2,233 deaths
- 98,876 Skin and subcutaneous tissue disorders incl. 185 deaths
- 5,415 Social circumstances incl. 27 deaths
- 25,013 Surgical and medical procedures incl. 251 deaths
- 52,095 Vascular disorders incl. 936 deaths
Total reactions for the mRNA vaccine SPIKEVAX/mRNA-1273 (CX-024414) from Moderna: 11,916 deaths and 720,662 injuries to 21/05/2022
- 19,456 Blood and lymphatic system disorders incl. 134 deaths
- 24,903 Cardiac disorders incl. 1,315 deaths
- 224 Congenital, familial and genetic disorders incl. 15 deaths
- 8,515 Ear and labyrinth disorders incl. 8 deaths
- 741 Endocrine disorders incl. 6 deaths
- 9,632 Eye disorders incl. 36 deaths
- 57,258 Gastrointestinal disorders incl. 451 deaths
- 190,630 General disorders and administration site conditions incl. 3,850 deaths
- 968 Hepatobiliary disorders incl. 64 deaths
- 8,062 Immune system disorders incl. 39 deaths
- 31,759 Infections and infestations incl. 1089 deaths
- 10,916 Injury, poisoning and procedural complications incl. 215 deaths
- 15,827 Investigations incl. 405 deaths
- 5,813 Metabolism and nutrition disorders incl. 282 deaths
- 89,472 Musculoskeletal and connective tissue disorders incl. 238 deaths
- 860 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 92 deaths
- 118,849 Nervous system disorders incl. 1,146 deaths
- 1,032 Pregnancy, puerperium and perinatal conditions incl. 13 deaths
- 120 Product issues incl. 3 deaths
- 11,834 Psychiatric disorders incl. 193 deaths
- 3,818 Renal and urinary disorders incl. 230 deaths
- 19,671 Reproductive system and breast disorders incl. 9 deaths
- 29,456 Respiratory, thoracic and mediastinal disorders incl. 1,264 deaths
- 37,258 Skin and subcutaneous tissue disorders incl. 107 deaths
- 2,747 Social circumstances incl. 45 deaths
- 5,716 Surgical and medical procedures incl. 218 deaths
- 15,125 Vascular disorders incl. 449 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 8,958 deaths and 1,267,883 injuries to 21/05/2022
- 14,856 Blood and lymphatic system disorders incl. 320 deaths
- 23,037 Cardiac disorders incl. 946 deaths
- 269 Congenital familial and genetic disorders incl. 10 deaths
- 14,620 Ear and labyrinth disorders incl. 7 deaths
- 784 Endocrine disorders incl. 6 deaths
- 21,601 Eye disorders incl. 33 deaths
- 114,466 Gastrointestinal disorders incl. 474 deaths
- 337,830 General disorders and administration site conditions incl. 2,084 deaths
- 1,154 Hepatobiliary disorders incl. 80 deaths
- 6,407 Immune system disorders incl. 44 deaths
- 54,461 Infections and infestations incl. 745 deaths
- 14,617 Injury poisoning and procedural complications incl. 219 deaths
- 30,652 Investigations incl. 223 deaths
- 14,191 Metabolism and nutrition disorders incl. 142 deaths
- 182,458 Musculoskeletal and connective tissue disorders incl. 188 deaths
- 854 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 50 deaths
- 252,545 Nervous system disorders incl. 1,298 deaths
- 698 Pregnancy puerperium and perinatal conditions incl. 22 deaths
- 205 Product issues incl. 1 death
- 22,791 Psychiatric disorders incl. 78 deaths
- 4,703 Renal and urinary disorders incl. 91 deaths
- 18,099 Reproductive system and breast disorders incl. 3 deaths
- 44,746 Respiratory thoracic and mediastinal disorders incl. 1,200 deaths
- 56,079 Skin and subcutaneous tissue disorders incl. 77 deaths
- 2,221 Social circumstances incl. 10 deaths
- 2,869 Surgical and medical procedures incl. 39 deaths
- 30,670 Vascular disorders incl. 568 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,877 deaths and 152,918 injuries to 21/05/2022
- 1,529 Blood and lymphatic system disorders incl. 65 deaths
- 3,353 Cardiac disorders incl. 244 deaths
- 55 Congenital, familial and genetic disorders incl. 2 deaths
- 1,688 Ear and labyrinth disorders incl. 3 deaths
- 135 Endocrine disorders incl. 2 deaths
- 2,012 Eye disorders incl. 12 deaths
- 10,769 Gastrointestinal disorders incl. 106 deaths
- 41,462 General disorders and administration site conditions incl. 816 deaths
- 191 Hepatobiliary disorders incl. 17 deaths
- 713 Immune system disorders incl. 11 deaths
- 12,281 Infections and infestations incl. 246 deaths
- 1,425 Injury, poisoning and procedural complications incl. 31 deaths
- 7,093 Investigations incl. 154 deaths
- 950 Metabolism and nutrition disorders incl. 77 deaths
- 19,497 Musculoskeletal and connective tissue disorders incl. 63 deaths
- 123 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 11 deaths
- 26,795 Nervous system disorders incl. 274 deaths
- 110 Pregnancy, puerperium and perinatal conditions incl. 1 death
- 34 Product issues
- 2,205 Psychiatric disorders incl. 31 deaths
- 666 Renal and urinary disorders incl. 43 deaths
- 3,864 Reproductive system and breast disorders incl. 6 deaths
- 5,401 Respiratory, thoracic and mediastinal disorders incl. 358 deaths
- 4,636 Skin and subcutaneous tissue disorders incl. 13 deaths
- 546 Social circumstances incl. 7 deaths
- 1,119 Surgical and medical procedures incl. 96 deaths
- 4,266 Vascular disorders incl. 188 deaths
Total reactions for the COVID-19 vaccine NUVAXOVID (NVX-COV2373) from Novavax: 0 deaths and 2,101 injuries to 21/05/2022
- 44 Blood and lymphatic system disorders
- 116 Cardiac disorders
- 26 Ear and labyrinth disorders
- 1 Endocrine disorders
- 46 Eye disorders
- 154 Gastrointestinal disorders
- 463 General disorders and administration site conditions
- 3 Hepatobiliary disorders
- 8 Immune system disorders
- 102 Infections and infestations
- 19 Injury, poisoning and procedural complications
- 57 Investigations
- 13 Metabolism and nutrition disorders
- 275 Musculoskeletal and connective tissue disorders
- 2 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- 373 Nervous system disorders
- 1 Pregnancy, puerperium and perinatal conditions
- 1 Product issues
- 36 Psychiatric disorders
- 11 Renal and urinary disorders
- 39 Reproductive system and breast disorders
- 105 Respiratory, thoracic and mediastinal disorders
- 142 Skin and subcutaneous tissue disorders
- 3 Social circumstances
- 9 Surgical and medical procedures
- 52 Vascular disorders
*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.
https://vaccineimpact.com/2022/44821-dead-4351483-injured-following-covid-19-vaccines-in-european-database-of-adverse-reactions/
Thanks to:https://vaccineimpact.com